Culturally adapted CBT for psychosis in Black people in the UK
Official title: Culturally-adapted Cognitive-behavioural Therapy for Black Sub-Saharan African and Caribbean People Experiencing Psychosis: A Case Series
Run by University of Manchester · NCT07252206 · Data updated 2026-11-12
A small series tests whether culturally tailored cognitive-behavioral therapy for psychosis is doable, acceptable, and safe for Black Sub-Saharan African and Caribbean individuals in the UK.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 6 (estimated) |
| Sponsor | University of Manchester Academic / other |
| Locations | 1 site (Manchester) |
| Status | Recruiting |
| Started | February 24, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT07252206 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Black British, Black Caribbean, Black African, or mixed African/Caribbean individuals with a schizophrenia-spectrum disorder who speak sufficient English and can participate in up to 16 CBT sessions.
✕Probably not a fit
Individuals with active substance use disorder, organic causes of psychosis, inability to consent, or current acute crisis may not benefit from this feasibility study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This case series evaluates the feasibility of culturally adapted CBT for psychosis among Black British, Caribbean, and African-descended individuals with psychosis or schizophrenia-spectrum disorders. Participants complete questionnaires, take part in up to 16 therapy sessions, and repeat measures to see changes, followed by a semi-structured interview about their therapy experience. The study focuses on practicality, acceptability, and safety rather than efficacy, and is conducted within the Greater Manchester area. The lead sponsor is the University of Manchester, in collaboration with the Greater Manchester Mental Health NHS Foundation Trust.
Why it matters
Potential benefit: If feasible and acceptable, the approach could lead to more accessible, culturally sensitive care for Black communities experiencing psychosis.
How similar studies have gone: Previous work suggests culturally tailored therapies can be feasible and acceptable in diverse populations, but data on psychosis-focused CBT for Black communities remain limited and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Service users who identify as Black British, Black Caribbean, Black African, African-Caribbean or Mixed African/Caribbean with at least one parent and/or grandparent born in a Sub-Saharan African or Caribbean country * People with a current ICD-10 schizophrenia spectrum disorder diagnosis, or who are currently receiving or have received support from an Early Intervention in Psychosis team * 16 years or older * Sufficient understanding of English to complete study measures and engage with CBTp Exclusion Criteria: * Current, primary diagnosis of substance use disorder * Organic aetiology of psychosis * Lacking capacity to provide full informed consent * Currently experiencing a mental health crisis (i.e., are open to a home-based treatment team; are currently under Section of the Mental Health Act or have been under Section in the past 3 months) or immediate high risk to self or others (i.e., current suicidal intent or plans; unmanaged and intense non-suicidal self-injury) * Currently receiving CBTp or received CBTp within the preceding 3 months * Unwilling to participate in culturally-adapted CBTp
Where it's running
-
Greater Manchester Mental Health NHS Foundation Trust
Manchester, United Kingdom Recruiting
Study contacts
- Study coordinator: Peter Panayi
- Email: peter.panayi@manchester.ac.uk
- Phone: +44161 306 6000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Trying the Kiso Mind smartphone app for people with schizophrenia spectrum disorders
This study tests whether the Kiso Mind smartphone app is acceptable, practical, and helpful for adults with schizophrenia or schizoaffective disorder alongside their usual care.
-
Examining the effects of combined therapy for schizophrenia
This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.
-
State Representation in Early Psychosis 2
This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.
-
Recovery-oriented suicide prevention for young people at clinical high risk for psychosis
This program tests a peer-supported, clinician-led suicide prevention group for young people at clinical high risk for psychosis to see if it helps reduce suicidal thoughts and support recovery.
-
Combined brain stimulation and yoga for improving cognition in psychosis
This study tests whether active brain stimulation plus yoga can improve thinking skills and daily function in adults with psychosis.
-
See if an early-detection program reduces time to treatment for first-episode psychosis
We test whether a large, region-wide early-detection program can shorten the time from first psychotic symptoms to treatment and help people function better later.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.